Clinically significant human papilloma virus in squamous cell carcinoma of the head and neck in UK practice

Clinical Oncology

Volumn 24, Issue 1, 2012, Pages

  Heath, S ^a   Willis, V ^a   Allan, K ^a   Purdie, K ^b   Harwood, C ^b   Shields, P ^a   Simcock, R ^a   Williams, T ^a   Gilbert, D C ^a  

^a ROYAL SUSSEX COUNTY HOSPITAL   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Head and neck squamous cell carcinoma; HPV; Oropharynx; P16; Radiotherapy

Indexed keywords

CETUXIMAB; CISPLATIN; CYCLIN DEPENDENT KINASE INHIBITOR 2A; VIRUS DNA;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHEMORADIOTHERAPY; CLINICAL PRACTICE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HEAD AND NECK CARCINOMA; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MOUTH CANCER; NONHUMAN; OROPHARYNX CANCER; OVERALL SURVIVAL; PAPILLOMAVIRUS INFECTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SALVAGE THERAPY; SQUAMOUS CELL CARCINOMA; TONGUE CANCER; TONSIL CANCER; TREATMENT RESPONSE; UNITED KINGDOM;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; DISEASE-FREE SURVIVAL; DNA, VIRAL; FEMALE; GREAT BRITAIN; HEAD AND NECK NEOPLASMS; HUMAN PAPILLOMAVIRUS 16; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOPLASM STAGING; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION;

EID: 84455189005     PISSN: 09366555     EISSN: 14332981     Source Type: Journal    
DOI: 10.1016/j.clon.2011.05.007     Document Type: Article

References (22)

1. Reddy V.M., Cundall-Curry D., Bridger M.W. Trends in the incidence rates of tonsil and base of tongue cancer in England, 1985-2006. Ann R Coll Surg Engl 2010, 92(8):655-659.
2. Evans M., Powell N.G. The changing aetiology of head and neck cancer: the role of human papillomavirus. Clin Oncol (R Coll Radiol) 2010, 22(7):538-546.
3. Hobbs C.G., Sterne J.A., Bailey M., Heyderman R.S., Birchall M.A., Thomas S.J. Human papillomavirus and head and neck cancer: a systematic review and meta-analysis. Clin Otolaryngol 2006, 31(4):259-266.
4. Marur S., D'Souza G., Westra W.H., Forastiere A.A. HPV-associated head and neck cancer: a virus-related cancer epidemic. Lancet Oncol 2010, 11(8):781-789.
5. Mork J., Lie A.K., Glattre E., et al. Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. NEngl J Med 2001, 344(15):1125-1131.
6. Begum S., Cao D., Gillison M., Zahurak M., Westra W.H. Tissue distribution of human papillomavirus 16 DNA integration in patients with tonsillar carcinoma. Clin Cancer Res 2005, 11(16):5694-5699.
7. Herrero R., Castellsague X., Pawlita M., et al. Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. JNatl Cancer Inst 2003, 95(23):1772-1783.
8. Anderson C.E., McLaren K.M., Rae F., Sanderson R.J., Cuschieri K.S. Human papilloma virus in squamous carcinoma of the head and neck: a study of cases in south east Scotland. JClin Pathol 2007, 60(4):439-441.
9. Fakhry C., Westra W.H., Li S., et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. JNatl Cancer Inst 2008, 100(4):261-269.
10. Lassen P., Eriksen J.G., Hamilton-Dutoit S., Tramm T., Alsner J., Overgaard J. Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck. JClin Oncol 2009, 27(12):1992-1998.
11. Hafkamp H.C., Speel E.J., Haesevoets A., et al. Asubset of head and neck squamous cell carcinomas exhibits integration of HPV 16/18 DNA and overexpression of p16INK4A and p53 in the absence of mutations in p53 exons 5-8. Int J Cancer 2003, 107(3):394-400.
12. Westra W.H., Taube J.M., Poeta M.L., Begum S., Sidransky D., Koch W.M. Inverse relationship between human papillomavirus-16 infection and disruptive p53 gene mutations in squamous cell carcinoma of the head and neck. Clin Cancer Res 2008, 14(2):366-369.
13. Kong C.S., Narasimhan B., Cao H., et al. The relationship between human papillomavirus status and other molecular prognostic markers in head and neck squamous cell carcinomas. Int J Radiat Oncol Biol Phys 2009, 74(2):553-561.
14. Kumar B., Cordell K.G., Lee J.S., et al. EGFR, p16, HPV titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer. JClin Oncol 2008, 26(19):3128-3137.
15. Moody C.A., Laimins L.A. Human papillomavirus oncoproteins: pathways to transformation. Nat Rev Cancer 2010, 10(8):550-560.
16. Scheffner M., Werness B.A., Huibregtse J.M., Levine A.J., Howley P.M. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 1990, 63(6):1129-1136.
17. Klingenberg B., Hafkamp H.C., Haesevoets A., et al. p16 INK4A overexpression is frequently detected in tumour-free tonsil tissue without association with HPV. Histopathology 2010, 56(7):957-967.
18. Weissenborn S.J., Funke A.M., Hellmich M., et al. Oncogenic human papillomavirus DNA loads in human immunodeficiency virus-positive women with high-grade cervical lesions are strongly elevated. JClin Microbiol 2003, 41(6):2763-2767.
19. Bauer H.M., Ting Y., Greer C.E., et al. Genital human papillomavirus infection in female university students as determined by a PCR-based method. Jama 1991, 265(4):472-477.
20. de Roda Husman A.M., Walboomers J.M., van den Brule A.J., Meijer C.J., Snijders P.J. The use of general primers GP5 and GP6 elongated at their 3' ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. JGen Virol 1995, 76(Pt 4):1057-1062.
21. Thavaraj S., Stokes A., Guerra E., et al. Evaluation of human papillomavirus testing for squamous cell carcinoma of the tonsil in clinical practice. JClin Pathol 2011, 64:308-312.
22. Bonner J.A., Harari P.M., Giralt J., et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. NEngl J Med 2006, 354(6):567-578.